Paris, France. February 13th, 2023 – Incepto, distributor, and co-creator of artificial intelligence (AI) solutions applied to medical imaging, signs a partnership with Avicenna.AI, developer of AI solutions for Radiology, and enriches its platform with new solutions for neurovascular pathologies such as stroke. All of these solutions are CE-cleared, and two are FDA marked. These solutions are now available via the Incepto platform in France, Germany, Italy, Spain, Portugal and Switzerland.
Worldwide, stroke affects between 12 and 15 million people each year*, meaning that 1 person out of 6 will suffer from a stroke in their lifetime. Despite improvements in primary care prevention and treatment, stroke is a devastating disease in the 21st century. Stroke is a leading cause of long-term disability and the second leading cause of death, with one death every 6 seconds worldwide*.
Three new artificial intelligence solutions for emergency care of neurovascular pathologies
CINA-ICH is a triage tool for detecting and prioritizing cases with traumatic brain injuries and hemorrhagic stroke on non-enhanced (non-contrast) head CT images. Five types of intracranial hemorrhages are detected: intraparenchymal, intraventricular, subarachnoid, subdural and epidural.
CINA-LVO is an ischemic stroke triage tool designed to detect LVO of the anterior circulation (distal ICA, M1, or proximal M2) on CT angiographies of the head.
CINA-ASPECTS is a quantitative tool that provides an ASPECT score on a non-enhanced head CT Scan, indicated for patients with acute ischemic stroke with known middle cerebral or carotid artery occlusion.
All of these solutions constitute the CINA Head suite. They enable to quickly detect and interpret the images, to reduce diagnostic errors while facilitating decision-making for doctors, and finally, to improve the quality of care for patients.
In stroke care, every minute counts. These new AI solutions reduce the time-to-treatment and improve patient outcomes and the quality of post-operative life.
Created in 2018, Incepto is the first European platform for artificial intelligence solutions applied to medical imaging. With a hundred clinics equipped with their AI solutions and already more than 100,000 patients monitored every month, Incepto’s mission is twofold: to help doctors identify the most efficient solutions and put them at their service, while co-creating new applications with them, adapted to their specific needs. Incepto’s ambition is to assist doctors on a daily basis in improving the accuracy of diagnoses, the treatment process and the quality of patient care. https://incepto-medical.com/fr
Founded in 2018, Avicenna.AI develops medical imaging AI solutions for highly prevalent pathologies. The company uses artificial intelligence and deep learning to optimize many of a radiologist’s manual tasks. Its CINA products leverage deep learning algorithms to identify acute abnormalities and to enhance clinicians’ workflow. Avicenna.AI is co-founded by Cyril Di Grandi, who previously co-founded and successfully sold Olea Medical, and Dr. Peter Chang, a radiologist and internationally recognized expert in AI and deep learning. www.avicenna.ai